Storb R, Weiden P L, Schroeder M L, Graham T C, Lerner K G, Thomas E D
Transplantation. 1976 Apr;21(4):299-306. doi: 10.1097/00007890-197604000-00005.
Hemopoietic grafts following 1,200 R of total body irradiation were carried out between canine littermates homozygous or heterozygous for lymphocyte defined (LD) antigens of the major histocompatibility complex (MHC). In all but five of the 25 pairs studied, LD homozygous dogs were also homozygous for serologically defined (SD) antigens of the MHC. Results of transplants were compared with previous results obtained in littermate pairs matched or mismatched for the MHC. Two groups of recipients were studied. Of 14 LD homozygous recipients in group 1 given grafts from LD heterozygous donors, 12 died between 8 and 193 days and two survived more than 238 and 627 days. The most frequent cause of death was graft-versus-host disease (GVHD). Survival was significantly shorter (P less than 0.005) than that of dogs given grafts from matched littermates and not different (P congruent to 0.5) from that of dogs given grafts from mismatched littermates. Survival of 11 LD heterozygous recipients in group 2 given grafts from LD homozygous donors was not different from that of dogs in group 1 (P congruent to 0.5). The results indicate that the LD loci detected by mixed leukocyte culture are not the principal determinants within the MHC that are responsible for GVHD.
在对主要组织相容性复合体(MHC)淋巴细胞定义(LD)抗原纯合或杂合的犬同窝仔之间,进行了全身照射1200伦琴后的造血移植。在研究的25对中,除5对外,所有LD纯合犬对MHC血清学定义(SD)抗原也是纯合的。将移植结果与先前在MHC匹配或不匹配的同窝仔对中获得的结果进行比较。研究了两组受体。在第1组中,14只接受LD杂合供体移植的LD纯合受体中,12只在8至193天之间死亡,2只存活超过238天和627天。最常见的死亡原因是移植物抗宿主病(GVHD)。其存活时间明显短于(P小于0.005)接受匹配同窝仔移植的犬,且与接受不匹配同窝仔移植的犬无差异(P等于0.5)。第2组中11只接受LD纯合供体移植的LD杂合受体的存活情况与第1组犬无差异(P等于0.5)。结果表明,通过混合淋巴细胞培养检测到的LD位点不是MHC内导致GVHD的主要决定因素。